[7,12,16-Trimethyl-15-(6-methyl-5-methylideneheptan-2-yl)-6-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl] 11-(3-pentyloxiran-2-yl)undec-9-enoate
| Internal ID | 82401e25-d6cc-4264-a168-e62637ac14d5 |
| Taxonomy | Lipids and lipid-like molecules > Steroids and steroid derivatives > Cycloartanols and derivatives |
| IUPAC Name | [7,12,16-trimethyl-15-(6-methyl-5-methylideneheptan-2-yl)-6-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl] 11-(3-pentyloxiran-2-yl)undec-9-enoate |
| SMILES (Canonical) | CCCCCC1C(O1)CC=CCCCCCCCC(=O)OC2CCC34CC35CCC6(C(CCC6(C5CCC4C2C)C)C(C)CCC(=C)C(C)C)C |
| SMILES (Isomeric) | CCCCCC1C(O1)CC=CCCCCCCCC(=O)OC2CCC34CC35CCC6(C(CCC6(C5CCC4C2C)C)C(C)CCC(=C)C(C)C)C |
| InChI | InChI=1S/C48H80O3/c1-9-10-17-20-41-42(50-41)21-18-15-13-11-12-14-16-19-22-44(49)51-40-28-30-47-33-48(47)32-31-45(7)38(36(5)24-23-35(4)34(2)3)27-29-46(45,8)43(48)26-25-39(47)37(40)6/h15,18,34,36-43H,4,9-14,16-17,19-33H2,1-3,5-8H3 |
| InChI Key | DQNQHBPMYYLQDU-UHFFFAOYSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C48H80O3 |
| Molecular Weight | 705.10 g/mol |
| Exact Mass | 704.61074641 g/mol |
| Topological Polar Surface Area (TPSA) | 38.80 Ų |
| XlogP | 16.30 |
| Atomic LogP (AlogP) | 13.60 |
| H-Bond Acceptor | 3 |
| H-Bond Donor | 0 |
| Rotatable Bonds | 20 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9959 | 99.59% |
| Caco-2 | - | 0.8322 | 83.22% |
| Blood Brain Barrier | + | 0.7500 | 75.00% |
| Human oral bioavailability | - | 0.7714 | 77.14% |
| Subcellular localzation | Mitochondria | 0.5189 | 51.89% |
| OATP2B1 inhibitior | - | 0.5692 | 56.92% |
| OATP1B1 inhibitior | + | 0.7951 | 79.51% |
| OATP1B3 inhibitior | + | 0.9478 | 94.78% |
| MATE1 inhibitior | - | 0.9600 | 96.00% |
| OCT2 inhibitior | - | 0.6000 | 60.00% |
| BSEP inhibitior | + | 0.9757 | 97.57% |
| P-glycoprotein inhibitior | + | 0.7475 | 74.75% |
| P-glycoprotein substrate | + | 0.6654 | 66.54% |
| CYP3A4 substrate | + | 0.7334 | 73.34% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.8570 | 85.70% |
| CYP3A4 inhibition | - | 0.6410 | 64.10% |
| CYP2C9 inhibition | - | 0.6244 | 62.44% |
| CYP2C19 inhibition | + | 0.6172 | 61.72% |
| CYP2D6 inhibition | - | 0.9230 | 92.30% |
| CYP1A2 inhibition | - | 0.6277 | 62.77% |
| CYP2C8 inhibition | + | 0.7425 | 74.25% |
| CYP inhibitory promiscuity | - | 0.5603 | 56.03% |
| UGT catelyzed | - | 0.0000 | 0.00% |
| Carcinogenicity (binary) | - | 0.9500 | 95.00% |
| Carcinogenicity (trinary) | Non-required | 0.6272 | 62.72% |
| Eye corrosion | - | 0.9874 | 98.74% |
| Eye irritation | - | 0.8993 | 89.93% |
| Skin irritation | - | 0.6213 | 62.13% |
| Skin corrosion | - | 0.9484 | 94.84% |
| Ames mutagenesis | - | 0.7954 | 79.54% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6579 | 65.79% |
| Micronuclear | - | 0.6200 | 62.00% |
| Hepatotoxicity | - | 0.5589 | 55.89% |
| skin sensitisation | - | 0.5305 | 53.05% |
| Respiratory toxicity | + | 0.5667 | 56.67% |
| Reproductive toxicity | + | 0.7556 | 75.56% |
| Mitochondrial toxicity | + | 0.7500 | 75.00% |
| Nephrotoxicity | - | 0.6270 | 62.70% |
| Acute Oral Toxicity (c) | III | 0.6649 | 66.49% |
| Estrogen receptor binding | + | 0.7723 | 77.23% |
| Androgen receptor binding | + | 0.7675 | 76.75% |
| Thyroid receptor binding | - | 0.5502 | 55.02% |
| Glucocorticoid receptor binding | + | 0.6568 | 65.68% |
| Aromatase binding | + | 0.5950 | 59.50% |
| PPAR gamma | + | 0.6450 | 64.50% |
| Honey bee toxicity | - | 0.7209 | 72.09% |
| Biodegradation | - | 0.7750 | 77.50% |
| Crustacea aquatic toxicity | + | 0.7778 | 77.78% |
| Fish aquatic toxicity | + | 1.0000 | 100.00% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.02% | 91.11% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 98.89% | 97.25% |
| CHEMBL2996 | Q05655 | Protein kinase C delta | 98.16% | 97.79% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.86% | 96.09% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 97.73% | 99.17% |
| CHEMBL233 | P35372 | Mu opioid receptor | 97.29% | 97.93% |
| CHEMBL240 | Q12809 | HERG | 97.09% | 89.76% |
| CHEMBL299 | P17252 | Protein kinase C alpha | 96.74% | 98.03% |
| CHEMBL2581 | P07339 | Cathepsin D | 96.26% | 98.95% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 95.32% | 94.45% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 95.18% | 92.86% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 94.13% | 95.17% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 93.58% | 96.95% |
| CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 92.95% | 96.61% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 92.95% | 96.38% |
| CHEMBL325 | Q13547 | Histone deacetylase 1 | 92.22% | 95.92% |
| CHEMBL5255 | O00206 | Toll-like receptor 4 | 92.21% | 92.50% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 92.18% | 89.63% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 92.17% | 90.17% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 91.76% | 100.00% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 91.43% | 100.00% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 91.36% | 97.09% |
| CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 91.28% | 96.00% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 91.24% | 96.47% |
| CHEMBL1966 | Q02127 | Dihydroorotate dehydrogenase | 91.08% | 96.09% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 90.39% | 95.71% |
| CHEMBL1914 | P06276 | Butyrylcholinesterase | 90.33% | 95.00% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 89.67% | 95.50% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 89.16% | 97.29% |
| CHEMBL2007625 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | 88.61% | 99.00% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 88.22% | 91.19% |
| CHEMBL2373 | P21730 | C5a anaphylatoxin chemotactic receptor | 87.53% | 92.62% |
| CHEMBL4303 | P08238 | Heat shock protein HSP 90-beta | 86.82% | 96.77% |
| CHEMBL236 | P41143 | Delta opioid receptor | 86.45% | 99.35% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 86.42% | 93.56% |
| CHEMBL4681 | P42330 | Aldo-keto-reductase family 1 member C3 | 86.30% | 89.05% |
| CHEMBL2265 | P23141 | Acyl coenzyme A:cholesterol acyltransferase | 86.12% | 85.94% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 85.89% | 97.50% |
| CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 85.83% | 95.58% |
| CHEMBL1907602 | P06493 | Cyclin-dependent kinase 1/cyclin B1 | 85.16% | 91.24% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 84.76% | 90.71% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 84.51% | 100.00% |
| CHEMBL4072 | P07858 | Cathepsin B | 84.31% | 93.67% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 83.80% | 98.10% |
| CHEMBL3837 | P07711 | Cathepsin L | 83.66% | 96.61% |
| CHEMBL3045 | P05771 | Protein kinase C beta | 83.64% | 97.63% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 83.63% | 93.00% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 83.59% | 96.25% |
| CHEMBL1293316 | Q9HBX9 | Relaxin receptor 1 | 83.56% | 82.50% |
| CHEMBL2243 | O00519 | Anandamide amidohydrolase | 83.46% | 97.53% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 82.92% | 91.81% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 82.44% | 95.89% |
| CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 82.18% | 86.33% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 81.83% | 98.75% |
| CHEMBL2179 | P04062 | Beta-glucocerebrosidase | 81.66% | 85.31% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 81.46% | 98.33% |
| CHEMBL4835 | P00338 | L-lactate dehydrogenase A chain | 80.86% | 95.34% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 80.47% | 90.08% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 80.11% | 92.88% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| Corymbia citriodora |
| PubChem | 162872522 |
| LOTUS | LTS0223112 |
| wikiData | Q104987051 |